Related Experiment Videos
Hypoplastic left heart syndrome: new developments and current controversies
Caren S Goldberg1, Carlen A Gomez
1Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology and the Congenital Heart Center, C. S. Mott Children's Hospital, University of Michigan Medical Center, Ann Arbor, MI 48109-0204, USA. Cgoldber@umich.edu
Seminars in Neonatology : SN
|March 6, 2004
Summary
Hypoplastic left heart syndrome (HLHS) survival has dramatically improved since 1980 due to surgical options. Ongoing research into fetal diagnosis and new interventions promises further advancements for this complex congenital heart disease.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Cardiac Surgery
Background:
- Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1980.
- Significant advancements in surgical palliation and heart transplantation have improved survival and quality of life for children with HLHS over the past 25 years.
Purpose of the Study:
- To explore current treatment strategies for HLHS.
- To review the ongoing controversies in managing this complex congenital cardiac disease.
Main Methods:
- Review of historical and current treatment approaches for HLHS.
- Discussion of evolving medical management, catheter interventions, and surgical techniques.
- Analysis of controversies in optimal treatment strategies.
Main Results:
- Operative options have transformed HLHS outcomes from uniformly lethal to improved survival and quality of life.
- Current advances in fetal diagnosis, medical management, and surgical techniques offer potential for further improvements.
Conclusions:
- Treatment strategies for HLHS have evolved significantly, leading to better patient outcomes.
- Despite progress, controversies persist regarding the optimal management of HLHS as new techniques emerge.